MX2018010105A - System for stabilization of human intestinal microbiota. - Google Patents

System for stabilization of human intestinal microbiota.

Info

Publication number
MX2018010105A
MX2018010105A MX2018010105A MX2018010105A MX2018010105A MX 2018010105 A MX2018010105 A MX 2018010105A MX 2018010105 A MX2018010105 A MX 2018010105A MX 2018010105 A MX2018010105 A MX 2018010105A MX 2018010105 A MX2018010105 A MX 2018010105A
Authority
MX
Mexico
Prior art keywords
microbiota
stabilized
intestinal microbiota
stabilization
human intestinal
Prior art date
Application number
MX2018010105A
Other languages
Spanish (es)
Inventor
Gonzalez Avila Marisela
Original Assignee
Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C filed Critical Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C
Priority to MX2018010105A priority Critical patent/MX2018010105A/en
Priority to PCT/MX2018/000114 priority patent/WO2020040631A1/en
Publication of MX2018010105A publication Critical patent/MX2018010105A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Algebra (AREA)
  • Pure & Applied Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Computational Mathematics (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Physics (AREA)
  • Biophysics (AREA)
  • Business, Economics & Management (AREA)
  • Educational Administration (AREA)
  • Educational Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a system of compositions and methods for obtaining, stabilizing, and applying an ex-vivo model of the gastrointestinal microbiota, useful in the simulation of digestion processes. Herein, the incorporation of the stabilized microbiota allows conducting a range of studies on populations of microorganisms from donors belonging to an interest group for any characteristics or conditions related to age, gender, genotype/phenotype, ethnicity, race, or geographic location. Also, relating to some specific alteration of the state of health caused by pathogens, nutritional aspects, obesity, kidney failure, metabolic disorders, among others. Further, the stabilized microbiota comes from a particular individual for use in simulations of digestive processes, to test therapies related to the formation of metabolites and the impact that they can have on the intestinal microbiota, for example in cases of inflammatory bowel disease.
MX2018010105A 2018-08-21 2018-08-21 System for stabilization of human intestinal microbiota. MX2018010105A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2018010105A MX2018010105A (en) 2018-08-21 2018-08-21 System for stabilization of human intestinal microbiota.
PCT/MX2018/000114 WO2020040631A1 (en) 2018-08-21 2018-10-26 System for stabilising human intestinal microbiota

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018010105A MX2018010105A (en) 2018-08-21 2018-08-21 System for stabilization of human intestinal microbiota.

Publications (1)

Publication Number Publication Date
MX2018010105A true MX2018010105A (en) 2020-02-24

Family

ID=69593346

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018010105A MX2018010105A (en) 2018-08-21 2018-08-21 System for stabilization of human intestinal microbiota.

Country Status (2)

Country Link
MX (1) MX2018010105A (en)
WO (1) WO2020040631A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354295B (en) * 2012-05-09 2018-02-09 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Process for the simulation of the human digestive tract.
EP2927327A1 (en) * 2014-04-02 2015-10-07 EntreChem, S.L. Non-invasive in vitro method for diagnosis and prognosis of colorectal cancer
MX366432B (en) * 2015-10-14 2019-06-14 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Automated system for simulating the human digestive tract.
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota
WO2018140931A1 (en) * 2017-01-30 2018-08-02 The Board Of Regents Of The University Of Texas System Compositions and methods for fecal microbiota transplantation

Also Published As

Publication number Publication date
WO2020040631A1 (en) 2020-02-27

Similar Documents

Publication Publication Date Title
Maruvada et al. The human microbiome and obesity: moving beyond associations
Yang et al. Gut dysbiosis is linked to hypertension
Quercia et al. From lifetime to evolution: timescales of human gut microbiota adaptation
Clarke et al. Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour
Sanmiguel et al. Surgically induced changes in gut microbiome and hedonic eating as related to weight loss: preliminary findings in obese women undergoing bariatric surgery
Bonfrate et al. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options
Stilling et al. Microbial genes, brain & behaviour–epigenetic regulation of the gut–brain axis
Li et al. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis
Stilling et al. Friends with social benefits: host-microbe interactions as a driver of brain evolution and development?
Stinson Establishment of the early-life microbiome: a DOHaD perspective
Tuohy et al. Diet-microbe interactions in the gut: Effects on human health and disease
Miller Jr The eukaryotic microbiome: origins and implications for fetal and neonatal life
MX2020003198A (en) Novel lactic acid bacteria and use thereof.
Begum et al. Epigenetics in depression and gut-brain axis: A molecular crosstalk
Arena et al. Functional starters for functional yogurt
BR112017006416A2 (en) nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
MX2018010105A (en) System for stabilization of human intestinal microbiota.
Lu et al. RETRACTED: Linking gut microbiota to aging process: a new target for anti-aging
Huang et al. Current situation and factors influencing physical fitness among adolescents aged 12∼ 15 in Shandong Province, China: A cross-sectional study
Corral et al. Seasonality of symptoms in women with postpartum depression
Carneiro et al. Lactobacillus plantarum ST202Ch and Lactobacillus plantarum ST216Ch–what are the limitations for application?
Farkas et al. Degenerative Cervical Myelopathy induces sex-specific dysbiosis in mice
Hill et al. P4-236 ALZHEIMER’S DISEASE AND THE MICROBIOME
Closter Quantitative genetic analysis of ascites in broilers
Milisav et al. Animal nutrition and breeding conditions modify the physiology of isolated primary cells